These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22932024)

  • 21. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcalar networks for policy transfer and implementation: the case of global health policies for malaria and HIV/AIDS in Cameroon.
    Ngoasong MZ
    Health Policy Plan; 2011 Jan; 26(1):63-72. PubMed ID: 20494940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated city-driven perinatal HIV prevention program covering 1.8 million pregnant women in Shenzhen, China, 2000 to 2010.
    Song J; Feng T; Bulterys M; Zhang D; Korhonen C; Shi X; Wang X; Cheng J; Chen L; Ma H
    Sex Transm Dis; 2013 Apr; 40(4):329-34. PubMed ID: 23486499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi.
    Tweya H; Gareta D; Chagwera F; Ben-Smith A; Mwenyemasi J; Chiputula F; Boxshall M; Weigel R; Jahn A; Hosseinipour M; Phiri S
    Trop Med Int Health; 2010 Jun; 15 Suppl 1():82-9. PubMed ID: 20586965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002.
    IAPAC Mon; 2002 Jun; 8(6):168-75. PubMed ID: 12154788
    [No Abstract]   [Full Text] [Related]  

  • 29. [Does the National HIV /AIDS Control programme provide support for district hospitals in Cameroon?].
    Keugoung B; Fotsing R; Macq J; Buve A; Marchal B; Meli J; Criel B
    Sante Publique; 2015; 27(4):547-56. PubMed ID: 26751929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I; van der Horst C
    J HIV Ther; 2004 Sep; 9(3):65-8. PubMed ID: 15534564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Access to the management of HIV infected children: Overview of the healthcare supply in Cameroon in 2014].
    Penda CI; Zoung Kanyi Bissek AC; Téjiokem MC; Sofeu CL; Eboumbou Moukoko EC; Ateba Ndongo F; Njock LR; Koki Ndombo PO
    Rev Epidemiol Sante Publique; 2020 Aug; 68(4):243-251. PubMed ID: 32631665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to second-line antiretroviral therapeutic regimens in low-resource settings: experiences from Cameroon.
    d'Almeida C; Essi MJ; Camara M; Coriat B
    J Acquir Immune Defic Syndr; 2011 Jul; 57 Suppl 1():S55-8. PubMed ID: 21857288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can modeling of HIV treatment processes improve outcomes? Capitalizing on an operations research approach to the global pandemic.
    Xiong W; Hupert N; Hollingsworth EB; O'Brien ME; Fast J; Rodriguez WR
    BMC Health Serv Res; 2008 Aug; 8():166. PubMed ID: 18680594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Health promotion in Cameroon: current situation and prospects].
    Ndjepel J; Ngangue P; Vii Mballa Elanga E
    Sante Publique; 2014; 26(1 Suppl):S35-8. PubMed ID: 25380375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.
    Hankins CA; Koulla-Shiro S; Kilmarx P; Ferrari G; Schechter M; Kane CT; Venter F; Boucher CA; Ross AL; Zewdie D; Eholié SP; Katabira E
    Antivir Ther; 2017; 22(2):179-184. PubMed ID: 28387654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for an enhanced HIV/AIDS policy and care in Cameroon: proceedings of the second Cameroon HIV Research Forum (CAM-HERO) 2021.
    Tchendjou P; Ebasone PV; Dzudie A; Khan EM; Fokam J; Muffih PT; Ndjolo A; Nyoto LB; Kouanfack C; Mabou G; Djikeussi T; Sih C; Ateudjieu J; Tchounga B; Tchakounte BY; Lekeumo S; Tabala FN; Atanga B; Simo L; Bakari M; Zemsi A; Nforbih ES; Ndayisaba G; Petnga SJ; Nguemo JL; Ngamani ML; Fon P; Nasah J; Neba E; Njie G; Ndiforkwah N; Semengue EN; Katayi T; Tene G; Nji PA; Njankou E; Agbornkwai N; Tiam A; Ditekemena J; Ndongmo C; Bwemba TA; Billong SC; Bisseck ACZ; Njock LR
    Pan Afr Med J; 2022; 43():92. PubMed ID: 36699972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Towards a new model of health care delivery in pharmaceutical care to the HIV+ patient].
    Morillo Verdugo R; Illaro Uranga A; Margusino Framinan L;
    Farm Hosp; 2013; 37(1):1-3. PubMed ID: 23461493
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on Greig et al, "Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-Saharan Africa".
    Spira TJ; Ellerbrock TV
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e82-4. PubMed ID: 22330609
    [No Abstract]   [Full Text] [Related]  

  • 39. Research for Health Care and Policy on HIV/AIDS: proceedings of the third edition of the Cameroon HIV Research (CAM-HERO) 2022, Kribi, Cameroon, from 1
    Dzudie A; Tchendjou P; Khan EM; Ajeh R; Thienemann F; Tiam A; Tchounga B; Fokam J; Ndongmo C; Ebasone PV; Mabou G; Goura AP; Shu EN; Katayi T; Nji PA; Ngamani ML; Lengouh C; Tabala FN; Takem EN; Bakor A; Nekame LG; Djikeussi T; Semengue ENJ; Fon KT; Chenwi C; Nasah JL; Ngeke GN; Tasha MR; Ndiforkwah N; Nyemb G; Nshom E; N Draman C; Wenze CA; Simo L; Ndayisaba G; Kang WK; Nka AD; Tchakounte BY; Lekeumo S; Neba E; Agbornkwai N; Bwemba TA; Muffih PT; Zoung-Kany Bisseck AC; Njock LR
    Pan Afr Med J; 2023; 46():6. PubMed ID: 37928216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A report on the research leadership and scientific writing training organized in Yaounde by the Clinical Research Education, Networking and Consultancy (CRENC) and the IeDEA-Cameroon team.
    Dzudie A; Njume E; Ajeh R; Yone-Pefura EW; Divine B; Adedimeji A; Anastos K
    Pan Afr Med J; 2018; 29():195. PubMed ID: 30061973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.